Campral

Product NDC
68151-4760
11-digit product format
681514760
Labeler code
68151
Product ID
68151-4760_e6f9c308-7699-48ef-8c70-c69e938521eb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
acamprosate calcium
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Labeler
Carilion Materials Management
Application
NDA021431
Marketing category
NDA
Marketing start
2005-01-11
Marketing end
0000-00-00
Substance
ACAMPROSATE CALCIUM
Active strength
333 mg/1
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c95d5956-8a83-9dba-bb9d-d7b5fb3324ecProduct name320170724

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68151-4760-0Campral1 in 1 PACKAGETABLET, DELAYED RELEASE13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
acamprosate calciumACTIVE INGREDIENT59375N1D0UCAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
acamprosateACTIVE MOIETYN4K14YGM3JCAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
CROSPOVIDONEINACTIVE INGREDIENT68401960MKCAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
MAGNESIUM SILICATEINACTIVE INGREDIENT9B9691B2N9CAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30CAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE AINACTIVE INGREDIENTNX76LV5T8JCAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3CAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2CAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
TALCINACTIVE INGREDIENT7SEV7J4R1UCAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68151-4760CAMPRAL (ACAMPROSATE CALCIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]3Legacy NDC, 1 package rows20160808_fe6f754f-62b4-4c86-805d-221332409516.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
835726acamprosate calcium 333 MG Delayed Release Oral TabletPSNfe6f754f-62b4-4c86-805d-2213324095163
835728Campral 333 MG Delayed Release Oral TabletPSNfe6f754f-62b4-4c86-805d-2213324095163
835728acamprosate calcium 333 MG Delayed Release Oral Tablet [Campral]SBDfe6f754f-62b4-4c86-805d-2213324095163
835726acamprosate calcium 333 MG Delayed Release Oral TabletSCDfe6f754f-62b4-4c86-805d-2213324095163
835726acamprosate calcium 333 MG (acamprosate 300 MG) Delayed Release Oral TabletSYfe6f754f-62b4-4c86-805d-2213324095163
835728Campral 333 MG (equivalent to acamprosate 300 MG) Delayed Release Oral TabletSYfe6f754f-62b4-4c86-805d-2213324095163

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
68151-4760-0681514760001 in 1 PACKAGEHistorical